Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorkspace Regulatory News (WKP)

Share Price Information for Workspace (WKP)

Share Price is delayed by 15 minutes
Get Live Data
335.20    -3.80 (-1.12%)
Bid:
334.40
Ask:
335.00
Spread: 0.60 (0.179%)
Market Cap: £644.55m
WKP Live PriceLast checked at - London Stock Exchange

Intraday Workspace Share Chart

Form 8.3 - Workspace Group plc

30 Mar 2022 16:51

RNS Number : 6568G
State Street Global Advisors
30 March 2022
 

Amendment Form:

This form is replacement of RNS ID - 4809F (Dated 21st March 2022)

Amendments Made: 2A - Transfer out comments are added

 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

State Street Global Advisors & Affiliates

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Workspace Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18-March-2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

Yes, McKay Securities plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

100p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,360,998

2.40772%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

4,360,998

2.40772%

The change in the holding of 183 shares since the last disclosure for dealing 15 March 2022 is due to the transfer out of a discretionary holding.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

100p ordinary

Purchase

1,243

GBP 6.605004

100p ordinary

Purchase

5,867

GBP 6.605001

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

30-March-2022

Contact name:

Lionel Colaco

Telephone number*:

020 33956098

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEASDEDLPAEFA
Date   Source Headline
24th Jun 202512:00 pmRNSDirector/PDMR Shareholding
13th Jun 20254:18 pmRNSPUBLICATION OF ANNUAL REPORT & NOTICE OF 2025 AGM
5th Jun 20257:00 amRNSWORKSPACE GROUP PLC FULL YEAR RESULTS
16th May 20257:00 amRNSPOST-CLOSE FINANCIAL UPDATE
17th Apr 20257:00 amRNSFOURTH QUARTER BUSINESS UPDATE
4th Apr 202510:02 amRNSHolding(s) in Company
3rd Apr 20257:00 amRNSAPPOINTMENT OF NEW HEAD OF PORTFOLIO MANAGEMENT
2nd Apr 20254:16 pmRNSHolding(s) in Company
21st Mar 20252:27 pmRNSHolding(s) in Company
26th Feb 20254:40 pmRNSHolding(s) in Company
24th Jan 202510:26 amRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSWORKSPACE GROUP PLC THIRD QUARTER BUSINESS UPDATE
9th Jan 202511:37 amRNSHolding(s) in Company
8th Jan 202512:39 pmRNSHolding(s) in Company
7th Jan 20257:03 amRNSDirector Declaration
2nd Jan 202510:39 amRNSBLOCK LISTING SIX MONTHLY RETURN
17th Dec 20244:05 pmRNSDirector/PDMR Shareholding
28th Nov 202412:59 pmRNSDirector/PDMR Shareholding
22nd Nov 20247:00 amRNSWORKSPACE GROUP PLC HALF YEAR RESULTS
13th Nov 20247:00 amRNSWORKSPACE OPENS ITS FIRST NET ZERO BUILDING
8th Nov 20247:00 amRNSWORKSPACE® ANNOUNCES DISPOSAL OF RAYNES PARK
24th Oct 20243:32 pmRNSHolding(s) in Company
22nd Oct 20247:04 amRNSCEO TRANSITION
18th Oct 20249:49 amRNSHolding(s) in Company
17th Oct 20249:50 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSWORKSPACE GROUP PLC SECOND QUARTER BUSINESS UPDATE
27th Sep 20242:22 pmRNSDirector/PDMR Shareholding
18th Sep 202412:02 pmRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSBlock Listing Application
22nd Aug 20244:52 pmRNSHolding(s) in Company
19th Aug 20249:43 amRNSHolding(s) in Company
9th Aug 20241:04 pmRNSHolding(s) in Company
29th Jul 20247:00 amRNSDisposal announcement
25th Jul 202412:49 pmRNSRESULTS OF ANNUAL GENERAL MEETING
24th Jul 20242:23 pmRNSDIRECTOR/PDMR SHAREHOLDING (AMENDMENT)
11th Jul 20247:00 amRNSQ1 Business Update
4th Jul 20244:08 pmRNSDirector/PDMR Shareholding
1st Jul 202412:03 pmRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jun 20241:45 pmRNSDirector/PDMR Shareholding
28th Jun 202410:15 amRNSDirector/PDMR Shareholding
26th Jun 20243:54 pmRNSVoting Rights and Share Capital
26th Jun 20243:51 pmRNSDirector/PDMR Shareholding
25th Jun 202410:24 amRNSDirector/PDMR Shareholding
24th Jun 202411:42 amRNSDirector/PDMR Shareholding
21st Jun 202410:17 amRNSDirector/PDMR Shareholding
13th Jun 202411:38 amRNSPUBLICATION OF ANNUAL REPORT & NOTICE OF 2024 AGM
5th Jun 20247:00 amRNSWORKSPACE GROUP PLC FULL YEAR RESULTS
8th May 20247:05 amRNSWorkspace CEO Succession Announcement
7th May 20247:00 amRNSHolding(s) in Company
25th Apr 20247:00 amRNSAPPOINTMENT OF NON-EXECUTIVE DIRECTOR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.